Home
About Agrenvec
Technology
Recombinant proteins
News
Location
News
Agrenvec closes its first commercial portfolio with the company ProSpec-Tany
2006/11/4 18:33:00
Agrenvec closes its first commercial portfolio with the company ProSpec-Tany for $420.000
Search
Work with us
Contact with Agrenvec
Legal advisory
Privacy policy
© Agrenvec, 2007 Spain – All rights reserved.
Legal information
